Vibegron
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 168 publications
Making the Most of Pharmacologic Interventions: Urodynamic Effects of Different Therapies for Neurogenic Lower Urinary Tract Dysfunction Following Spinal Cord Injury.
Journal: European urology focus
Published: March 23, 2026
Synergistic CRISPR-Cas9 Host Engineering and Enzyme Evolution for Enantioselective Synthesis of a Vibegron Pyrrolidine Intermediate.
Journal: Organic letters
Published: March 16, 2026
Real-world persistence of vibegron in patients aged ≥ 80 years with overactive bladder: a multicenter cohort study.
Journal: World journal of urology
Published: February 01, 2026
Editorial Comment: Safety and efficacy of vibegron in pediatric patients with treatment-resistant nocturnal enuresis: a multicenter retrospective study
Journal: International braz j urol : official journal of the Brazilian Society of Urology
Published: January 23, 2026
A novel electrochemical sensor for the analysis of vibegron as a newly approved FDA drug: a rational computational design and cleaning validation application.
Journal: Analytical methods : advancing methods and applications
Published: January 16, 2026
Editorial Comment on: Use and Persistence of Beta-3 Adrenoceptor Agonists for the Treatment of Overactive Bladder.
Journal: International journal of urology : official journal of the Japanese Urological Association
Published: December 08, 2025
Effects of Treatment and Weather Variables on Nocturnal Enuresis: Long-Term Analysis Using the Classification and Regression Trees Model.
Journal: Cureus
Published: December 02, 2025
Efficacy and Safety of Vibegron Add-On Therapy for Persistent Overactive Bladder Symptoms in Benign Prostatic Hyperplasia Patients With α1-Blocker Treatment: A Multi-Center Prospective Randomized Controlled Study (VATON Study).
Journal: Lower urinary tract symptoms
Published: November 29, 2025
Microwave-assisted N,S doped carbon quantum dots as fluorescent nanoprobes for vibegron determination: face-centered design optimization, validation, and green chemistry assessment.
Journal: RSC advances
Published: November 19, 2025
Correction to: Vibegron in overactive bladder: a comprehensive review of efficacy, safety and patient-reported outcomes.
Journal: World journal of urology
Published: November 03, 2025
Comparative assessment of oral medications for overactive bladder in older adults: a systematic review and network meta-analysis.
Journal: The aging male : the official journal of the International Society for the Study of the Aging Male
Published: October 29, 2025
β3-Adrenoceptor Agonists for Neurogenic Lower Urinary Tract Dysfunction: Evidence and Clinical Rationale for First-Line Therapy.
Journal: Neurourology and urodynamics
Published: October 09, 2025
Last Updated: 04/28/2026